CIK 0001479419 · Non-accelerated filer<br>Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270604595
- Phone
- 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-04 | Reumuth Mary CHIEF FINANCIAL OFFICER | Sale | −60 | $28.54 | $2K | 11,883 |
| 2023-01-04 | Brazzell Romulus K SEE REMARKS | Grant or award | +12,800 | 18,609 | ||
| 2023-01-04 | Brazzell Romulus K SEE REMARKS | Sale | −73 | $28.53 | $2K | 18,536 |
| 2023-01-04 | Bazemore Todd SEE REMARKS | Grant or award | +12,800 | 14,897 | ||
| 2023-01-04 | Bazemore Todd SEE REMARKS | Sale | −62 | $28.54 | $2K | 14,835 |
| 2023-01-04 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Grant or award | +41,700 | 46,164 | ||
| 2023-01-04 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Sale | −198 | $28.54 | $6K | 45,966 |
| 2022-10-31 | Farid Marjan Director | Grant or award · Stock Option (right to buy) | +1,600 | 1,600 | ||
| 2022-10-26 | Trachtenberg Eric SEE REMARKS | Sale | −194 | $6.52 | $1K | 2,030 |
| 2022-10-26 | Bazemore Todd SEE REMARKS | Sale | −214 | $6.51 | $1K | 2,097 |
| 2022-10-26 | Reumuth Mary CHIEF FINANCIAL OFFICER | Sale | −194 | $6.51 | $1K | 2,418 |
| 2022-10-26 | Brazzell Romulus K SEE REMARKS | Sale | −261 | $6.51 | $2K | 5,809 |
| 2022-10-26 | Iwicki Mark T CHIEF EXECUTIVE OFFICER | Sale | −561 | $6.52 | $4K | 4,464 |
| 2022-06-27 | Trachtenberg Eric SEE REMARKS | Sale | −2,613 | $0.37 | $967 | 111,203 |
| 2022-06-27 | Reumuth Mary CHIEF FINANCIAL OFFICER | Sale | −2,613 | $0.37 | $967 | 130,595 |
| 2022-02-15 | Kharabi Darius CHIEF BUSINESS OFFICER | Other disposition | −9 | 15,430 |
Page 12 of 12 · 236 trades